- Report
- March 2023
- 100 Pages
Africa
From €1766EUR$2,000USD£1,525GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$4,246USD£3,129GBP
- Report
- May 2026
- 20 Pages
Europe
From €1678EUR$1,900USD£1,449GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
North America
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- January 2026
- 114 Pages
Global
From €3500EUR$4,246USD£3,129GBP
- Report
- June 2022
- 86 Pages
Global
From €3500EUR$4,246USD£3,129GBP
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United States
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
North America
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
Middle East
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
Asia Pacific
From €3523EUR$3,990USD£3,043GBP
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United States
From €3523EUR$3,990USD£3,043GBP
- Report
- May 2026
United Kingdom
From €3523EUR$3,990USD£3,043GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more